Depressive Symptoms, Coronary Heart Disease, and Overall Mortality in the Framingham Heart Study
Lawson R. Wulsin, MD,
Jane C. Evans, DSc,
Ramachandran S. Vasan, MD,
Joanne M. Murabito, MD, ScM,
Margaret Kelly-Hayes, EdD and
Emelia J. Benjamin, MD, ScM
From the Departments of Psychiatry and Family Medicine, University of Cincinnati, Cincinnati, Ohio (L.R.W.); The National Heart, Lung, & Blood Institute's Framingham Heart Study, Framingham, Massachusetts (J.C.E., R.S.V., J.M.M., M.K.-H., E.J.B.); The Division of Cardiology & Preventive Medicine and Neurology, Boston Medical Center, Boston, Massachusetts (J.C.E., R.S.V., M.K.-H., E.J.B.); The Section of General Internal Medicine, Boston Medical Center, Boston, Massachusetts (J.M.M.).

View larger version (35K):
[in a new window]
|
Figure 1. Percentage of Framingham Heart Study participants with CES-D score 16, by age and sex.
|
|
Copyright © 2005 by the American Psychosomatic Society